Summary:
A French pharmaceutical company is specialized in veterinary medicines. For one of its veterinary drugs, the company is looking for a manufacturer - Contract Manufacturing Organisation (CMO) - to produce tablets. The partner sought must have a veterinary grade and be able to manufacture in a GMP (good manufacturing practices) unit for solid form. A manufacturing agreement is sought.
Description:
A French veterinary medecines laboratory develops and supplies veterinary products with a very comprehensive range of solutions, tailored to all the situations animal may encounter: medicinal products, feed supplements, skincare, insect repellents etc.
The laboratory is looking for a Contract Manufacturing Organisation (CMO) able to produce chewable tablets for animals. The partner sought must have a veterinary grade and be able to manufacture in a GMP (good manufacturing practices) unit for solid form.
For this drug, the French company has the marketing authorization file approved by the competent authorities.
The French company could provide the active pharmaceutical ingredient (API) to the CMO. This is an API veterinary only. This API is not highly active.
The French company will need these tablets in bottle and/or in blister packs.
The estimated quantity is 1 million to 1,5 million of tablets per year.
A manufacturing agreement is sought to produce the drug according to the good manufacturing practices (GMP).
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
For this manufacturing agreemeent, a CMO is sought.
The partner has to be an industrial with good manufacturing practices (GPM) unit for solid form. It could be specialized in veterinary or human pharmaceutical drugs. The partner has to be able to produce these chewable tablets in bottle and/or in blister packs.
The size of the company does not matter: could be from 11 to more than 500 employees.
Technical Specification or Expertise Sought:
- Able to produce veterinary drugs in tablets
- Able to pack in small bottles and/or blister packs
- Able to produce small batches (1 to 1,5M of tablets per year)
- GMP unit for solid form (European standards).
Stage of Development:
Already on the market
IPR Status:
Granted patent or patent application essential
External code:
TRFR20210122001
